Thompson Oncology Group-Oak Ridge
Oak Ridge, Tennessee, United States
Cancer treatment center in Oak Ridge, Tennessee
200 New York Ave, Oak Ridge, TN 37830
About Thompson Oncology Group-Oak Ridge
"When you have cancer, you want the best physicians fighting for you. That’s why the physicians of Thompson Oncology Group are board-certified and fellowship-trained with only one mission: to eradicate your cancer. Our oncologists use proven drug-based treatments and the latest clinical trial medicines to ensure you receive the most effective treatment."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Thompson Oncology Group-Oak Ridge
During the past decade, Thompson Oncology Group-Oak Ridge conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on
average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
2014-06-01
2015-11-01
Completed
184
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Thompson Oncology Group-Oak Ridge" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "SWOG Cancer Research Network" with 5 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "NRG Oncology" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Thompson Oncology Group-Oak Ridge"
#1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Thompson Oncology Group-Oak Ridge
According to Clinical.Site data, the most researched conditions in "Thompson Oncology Group-Oak Ridge" are
"Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Colon Adenocarcinoma" (2 trials), "Recurrent Melanoma" (2 trials) and "Recurrent Ovarian Carcinoma" (2 trials). Many other conditions were trialed in "Thompson Oncology Group-Oak Ridge" in a lesser frequency.
Clinical Trials Intervention Types at Thompson Oncology Group-Oak Ridge
Most popular intervention types in "Thompson Oncology Group-Oak Ridge" are "Drug" (15 trials), "Other" (14 trials), "Biological" (10 trials), "Procedure" (9 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Computed Tomography" (7 trials), "Quality-of-Life Assessment" (7 trials), "Laboratory Biomarker Analysis" (6 trials), "Nivolumab" (6 trials) and "Biospecimen Collection" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Thompson Oncology Group-Oak Ridge
The vast majority of trials in "Thompson Oncology Group-Oak Ridge" are
18 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Thompson Oncology Group-Oak Ridge
Currently, there are NaN active trials in "Thompson Oncology Group-Oak Ridge".
undefined are not yet recruiting,
4 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Thompson Oncology Group-Oak Ridge,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Thompson Oncology Group-Oak Ridge, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".